102.09
전일 마감가:
$103.22
열려 있는:
$102.99
하루 거래량:
599.54K
Relative Volume:
0.79
시가총액:
$5.93B
수익:
$507.44M
순이익/손실:
$-187.69M
주가수익비율:
-31.21
EPS:
-3.271
순현금흐름:
$-39.06M
1주 성능:
+4.40%
1개월 성능:
-12.82%
6개월 성능:
+22.31%
1년 성능:
+0.84%
Glaukos Corporation Stock (GKOS) Company Profile
명칭
Glaukos Corporation
전화
949-367-9600
주소
1 GLAUKOS WAY, ALISO VIEJO, CA
Compare GKOS vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
GKOS
Glaukos Corporation
|
102.09 | 5.99B | 507.44M | -187.69M | -39.06M | -3.271 |
|
ABT
Abbott Laboratories
|
107.19 | 188.52B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
339.76 | 132.34B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
86.87 | 111.97B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
69.89 | 105.77B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
82.46 | 47.98B | 6.07B | 1.06B | 1.34B | 1.8063 |
Glaukos Corporation Stock (GKOS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-27 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2025-10-01 | 개시 | Goldman | Buy |
| 2025-05-01 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2025-02-19 | 업그레이드 | Mizuho | Neutral → Outperform |
| 2024-12-11 | 업그레이드 | Citigroup | Neutral → Buy |
| 2024-12-06 | 개시 | UBS | Buy |
| 2024-12-02 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2024-07-10 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-05-06 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-12-21 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2023-12-04 | 개시 | Morgan Stanley | Equal-Weight |
| 2023-11-28 | 개시 | Truist | Buy |
| 2023-11-08 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2023-06-07 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2022-12-22 | 개시 | Mizuho | Neutral |
| 2022-12-19 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2022-12-12 | 업그레이드 | Citigroup | Neutral → Buy |
| 2022-10-14 | 재개 | Stephens | Overweight |
| 2022-10-04 | 개시 | Needham | Buy |
| 2022-07-12 | 업그레이드 | Stifel | Hold → Buy |
| 2022-02-03 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2022-01-19 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2022-01-18 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2021-11-03 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2021-07-26 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2021-07-20 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
| 2021-07-14 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2021-07-14 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2021-04-08 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2021-01-29 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2020-12-16 | 업그레이드 | Citigroup | Sell → Neutral |
| 2020-12-09 | 개시 | Oppenheimer | Perform |
| 2020-11-17 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2020-10-08 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2020-06-15 | 개시 | Jefferies | Hold |
| 2020-03-05 | 개시 | Citigroup | Sell |
| 2020-02-28 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2020-01-06 | 업그레이드 | Berenberg | Hold → Buy |
| 2019-12-12 | 다운그레이드 | Wells Fargo | Outperform → Underperform |
| 2019-09-30 | 다운그레이드 | BofA/Merrill | Buy → Underperform |
| 2019-03-08 | 개시 | BTIG Research | Neutral |
| 2018-08-30 | 개시 | Berenberg | Hold |
| 2018-08-29 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2018-08-03 | 재확인 | Stifel | Hold |
| 2018-06-21 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2018-04-13 | 다운그레이드 | Stifel | Buy → Hold |
| 2018-03-01 | 재확인 | Cantor Fitzgerald | Buy |
| 2017-03-02 | 재확인 | Cantor Fitzgerald | Overweight |
| 2017-01-06 | 업그레이드 | Stifel | Hold → Buy |
| 2016-10-27 | 개시 | Wells Fargo | Outperform |
모두보기
Glaukos Corporation 주식(GKOS)의 최신 뉴스
Glaukos (NYSE:GKOS) CFO Alex Thurman Sells 625 Shares - MarketBeat
Glaukos SVP Thurman sells $61,968 in GKOS stock - Investing.com
Navratil, Glaukos corp officer, sells $101k in GKOS stock - Investing.com UK
Glaukos (NYSE: GKOS) CDO reports 1,031-share sale and tax withholding - Stock Titan
Glaukos (NYSE: GKOS) CFO sells 625 shares under 10b5-1 plan - Stock Titan
GLAUKOS (NYSE: GKOS) COO reports tax-withholding of 1,189 vested shares - Stock Titan
[Form 4] GLAUKOS Corp Insider Trading Activity - Stock Titan
Glaukos' Epioxa now commercially available in the US - Eyes On Eyecare
Glaukos Announces Commercial Availability of Epioxa™, a Transformative Innovation in Interventional Keratoconus Care - BioSpace
Why Is Glaukos (GKOS) Down 14.7% Since Last Earnings Report? - Yahoo Finance
Glaukos Announces Commercial Availability of Epioxa™, a Transformative Innovation in Interventional - pharmiweb.com
Glaukos Corporation Announces Commercial Availability Of Epioxa HD / Epioxa For Keratoconus Treatment - marketscreener.com
Glaukos Launches Epioxa for Keratoconus Treatment - marketscreener.com
Glaukos (GKOS) Launches Epioxa HD for Keratoconus Treatment - GuruFocus
Glaukos announces commercial availability of Epioxa HD/Epioxa - TipRanks
(GKOS) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Glaukos Corporation (NYSE:GKOS) Q4 2025 earnings call transcript - MSN
Glaukos (NYSE: GKOS) CDO reports tax-withholding of 1,074 shares - Stock Titan
Glaukos (GKOS) CEO Burns reports 5,212-share tax withholding and large trust holdings - Stock Titan
[144] GLAUKOS Corp SEC Filing - Stock Titan
Glaukos Corporation $GKOS Shares Sold by Holocene Advisors LP - MarketBeat
Cinctive Capital Management LP Makes New Investment in Glaukos Corporation $GKOS - MarketBeat
Alliancebernstein L.P. Has $141.37 Million Holdings in Glaukos Corporation $GKOS - MarketBeat
SpyGlass Valued at $900M After IPO - Orange County Business Journal
Glaukos Corporation $GKOS Shares Purchased by Iron Triangle Partners LP - MarketBeat
Fred Alger Management LLC Sells 109,170 Shares of Glaukos Corporation $GKOS - MarketBeat
Truist Securities maintains Glaukos (GKOS) buy recommendation - MSN
Braidwell LP Acquires 176,750 Shares of Glaukos Corporation $GKOS - MarketBeat
GKOS Stock Falls -20% In 9-day Spree On Earnings Shock - Trefis
Integral Health Asset Management LLC Acquires 50,000 Shares of Glaukos Corporation $GKOS - MarketBeat
Capital International Investors Buys 264,971 Shares of Glaukos Corporation $GKOS - MarketBeat
Glaukos Corporation (GKOS) Stock Price Today | Live Chart & News - Traders Union
Citi Sticks to Its Buy Rating for Glaukos (GKOS) - The Globe and Mail
Atika Capital Management LLC Has $17.32 Million Position in Glaukos Corporation $GKOS - MarketBeat
Here's Why You Should Retain Glaukos Stock in Your Portfolio - MSN
Glaukos Corporation (GKOS) Stock Price History & Data - Traders Union
Zacks Research Has Negative Outlook of Glaukos Q1 Earnings - MarketBeat
Zacks Research Weighs in on Glaukos FY2028 Earnings - MarketBeat
Glaukos (NYSE: GKOS) CEO has 1,098 shares withheld for taxes - Stock Titan
Canaloplasty Market Is Going to Boom |• Glaukos Corporation • Aquesys Inc - openPR.com
Citigroup Inc. Sells 34,689 Shares of Glaukos Corporation $GKOS - MarketBeat
(GKOS) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
GKOS Earnings History & Surprises | EPS & Revenue Results | GLAUKOS CORP (NYSE:GKOS) - ChartMill
Performance Recap: Is Glaukos Corporation affected by consumer sentimentJuly 2025 News Drivers & AI Forecasted Stock Moves - baoquankhu1.vn
TD Asset Management Inc Takes Position in Glaukos Corporation $GKOS - MarketBeat
Glaucoma Surgery Device Market Is Going to Boom | Glaukos Corporation • Santen Pharmaceutical • Carl Zeiss AG - openPR.com
Glaukos Corporation $GKOS Shares Purchased by AustralianSuper Pty Ltd - MarketBeat
GKOS Should I Buy - Intellectia AI
Glaukos’ 2025 Loss, Impairment and ESOP Shelf Might Change The Case For Investing In GKOS - simplywall.st
Glaukos Corporation (GKOS) Stock Analysis: Potential 11.95% Upside Amid Robust Revenue Growth - DirectorsTalk Interviews
William Blair Investment Management LLC Has $89.20 Million Holdings in Glaukos Corporation $GKOS - MarketBeat
Glaukos Corporation (GKOS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):